Annalisa D'Andrea
InvestorVenture Partner at Longwood Fund
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
Find your path to Annalisa
396 people in our graph share verified history with Annalisa — schools, employers, funds. One of them is your warm intro.
About
D'Andrea is a Venture Partner at Longwood Fund with over 25 years of experience in drug discovery, translational medicine, and R&D strategy across biotech and pharmaceutical companies. She has served as Chief Scientific Officer and board director at multiple organizations, leading scientific teams and advising on portfolio strategy, business development, and early-stage drug development. Currently, she focuses on board service and strategic advisory roles supporting companies and investors on translational planning, due diligence, and R&D decision-making.
Experience
- Longwood FundVenture Partnercurrent2021 — presentBoston, Massachusetts, United States
- Spero TherapeuticsAdvisorcurrent2026 — presentBoston, MA
- ProtaiMember of the Board of Advisorscurrent2025 — present
- Immunitas TherapeuticsChief Scientific Officer2024 — 2026United States
- Engimmune TherapeuticsIndependent Board Director2023 — 2026Basel, Switzerland
- ImmuneIDPresident and Chief Scientific Officer2021 — 2023Waltham, Massachusetts, United States
- Kiniksa PharmaceuticalsChief Scientific Officer2019 — 2021Lexington, Massachusetts
- RocheVP, Global Head Immunology & Inflammation Discovery, Roche Pharma Research & Early Development2015 — 2019Basel Area, Switzerland
- SRI InternationalExecutive Director, Discovery Biology2015Menlo Park, California
- SRI InternationalSenior Director Center for Immunology and Infectious Diseases2008 — 2014Menlo Park, CA
- SRI InternationalDirector, Center for Immunology2003 — 2007Menlo Park-CA
- SRI InternationalSenior Immunologist2000 — 2003Menlo Park-CA
- Inflammation Research AssociationSecretary2014 — 2015
- Chiron VaccinesConsultant1998 — 2000Siena-Italy
- DNAX Research InstitutePost Doctoral Fellow1994 — 1997Palo Alto-CA
- The Wistar InstituteGraduate Student1991 — 1994
Skills & more
+10 more
Cell BiologyAutoimmune DiseasesInflammationVaccinespreclinical developmentIn VitroAssay DevelopmentFlow CytometryELISAPharmaceutical IndustryLanguages Italian
From Annalisa's professional profile.
Colleagues at Longwood Fund
Network4
Investors connected to Annalisa in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Annalisa D'Andrea?
- D'Andrea is a Venture Partner at Longwood Fund with over 25 years of experience in drug discovery, translational medicine, and R&D strategy across biotech and pharmaceutical companies. She has served as Chief Scientific Officer and board director at multiple organizations, leading scientific teams and advising on portfolio strategy, business development, and early-stage drug development. Currently, she focuses on board service and strategic advisory roles supporting companies and investors on translational planning, due diligence, and R&D decision-making.
- Where does Annalisa D'Andrea work?
- Annalisa D'Andrea is Venture Partner at Longwood Fund.
- What check size does Annalisa D'Andrea write?
- Annalisa D'Andrea typically writes checks of $100K – $5M.
- Where did Annalisa D'Andrea go to school?
- Annalisa D'Andrea studied at University of Pennsylvania (Graduate Student, Immunology); Università degli Studi di Firenze (PhD, Immunology); Università di Siena (Master in Biology, Microbiology and Immunology).
Same school
Also attended University of Pennsylvania1,415
+ 1,409 more
Also attended Università degli Studi di Firenze42
+ 36 more
Also attended Università di Siena17
+ 11 more
Shared employers
Also worked at Immunitas Therapeutics5
Also worked at Roche228
+ 222 more
Also worked at Chiron Vaccines32
+ 26 more























































